BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11891009)

  • 1. N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries.
    Brekke JF; Osol GJ; Helle KB
    Regul Pept; 2002 May; 105(2):93-100. PubMed ID: 11891009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasostatins. Dilators of bovine resistance arteries.
    Brekke JF; Kirkeleit J; Lugardon K; Helle KB
    Adv Exp Med Biol; 2000; 482():239-46. PubMed ID: 11192585
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart.
    Corti A; Mannarino C; Mazza R; Angelone T; Longhi R; Tota B
    Gen Comp Endocrinol; 2004 Apr; 136(2):217-24. PubMed ID: 15028525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery.
    MandalĂ  M; Brekke JF; Serck-Hanssen G; Metz-Boutigue MH; Helle KB
    Regul Pept; 2005 Jan; 124(1-3):73-80. PubMed ID: 15544843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.
    Russell J; Gee P; Liu SM; Angeletti RH
    Endocrinology; 1994 Jul; 135(1):337-42. PubMed ID: 8013369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
    Stridsberg M; Angeletti RH; Helle KB
    J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion.
    Drees BM; Rouse J; Johnson J; Hamilton JW
    Endocrinology; 1991 Dec; 129(6):3381-7. PubMed ID: 1954912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of chromogranin-derived antimicrobial peptides in plasma during coronary artery bypass surgery and evidence of an immune origin of these peptides.
    Tasiemski A; Hammad H; Vandenbulcke F; Breton C; Bilfinger TJ; Pestel J; Salzet M
    Blood; 2002 Jul; 100(2):553-9. PubMed ID: 12091348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
    Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
    Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptolepine-induced vasodilation in the isolated perfused kidney of the rat: role of G-proteins, K+ and Ca2+ channels.
    Oyekan AO
    Eur J Pharmacol; 1995 Oct; 285(1):1-9. PubMed ID: 8846804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.
    Tota B; Mazza R; Angelone T; Nullans G; Metz-Boutigue MH; Aunis D; Helle KB
    Regul Pept; 2003 Jul; 114(2-3):123-30. PubMed ID: 12832100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
    Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
    Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon.
    Amato A; Corti A; Serio R; Mulè F
    Regul Pept; 2005 Aug; 130(1-2):42-7. PubMed ID: 15869818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of natural vasostatin-containing peptides in rat heart.
    Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
    FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent and BRL 34915-induced vasodilatation in rat isolated perfused mesenteric arteries: role of G-proteins, K+ and calcium channels.
    Adeagbo AS; Malik KU
    Br J Pharmacol; 1990 Jul; 100(3):427-34. PubMed ID: 2167732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.
    Lugardon K; Raffner R; Goumon Y; Corti A; Delmas A; Bulet P; Aunis D; Metz-Boutigue MH
    J Biol Chem; 2000 Apr; 275(15):10745-53. PubMed ID: 10753865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion.
    Angeletti RH; Mints L; Aber C; Russell J
    Endocrinology; 1996 Jul; 137(7):2918-22. PubMed ID: 8770914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary arteriolar dilation to acidosis: role of ATP-sensitive potassium channels and pertussis toxin-sensitive G proteins.
    Ishizaka H; Gudi SR; Frangos JA; Kuo L
    Circulation; 1999 Feb; 99(4):558-63. PubMed ID: 9927404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action.
    Imbrogno S; Angelone T; Corti A; Adamo C; Helle KB; Tota B
    Gen Comp Endocrinol; 2004 Oct; 139(1):20-8. PubMed ID: 15474532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.